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2Abstract. In competing event settings, a counterfactual contrast of cause-specific cu-
mulative incidences quantifies the total causal effect of a treatment on the event of inter-
est. However, effects of treatment on the competing event may indirectly contribute to
this total effect, complicating its interpretation. We previously proposed the separable
effects (Stensrud et al, 2019) to define direct and indirect effects of the treatment on
the event of interest. This definition presupposes a treatment decomposition into two
components acting along two separate causal pathways, one exclusively outside of the
competing event and the other exclusively through it. Unlike previous definitions of
direct and indirect effects, the separable effects can be subject to empirical scrutiny in a
study where separate interventions on the treatment components are available. Here we
extend and generalize the notion of the separable effects in several ways, allowing for in-
terpretation, identification and estimation under considerably weaker assumptions. We
propose and discuss a definition of separable effects that is applicable to general time-
varying structures, where the separable effects can still be meaningfully interpreted,
even when they cannot be regarded as direct and indirect effects. We further derive
weaker conditions for identification of separable effects in observational studies where
decomposed treatments are not yet available; in particular, these conditions allow for
time-varying common causes of the event of interest, the competing events and loss to
follow-up. For these general settings, we propose semi-parametric weighted estimators
that are straightforward to implement. As an illustration, we apply the estimators to
study the separable effects of intensive blood pressure therapy on acute kidney injury,
using data from a randomized clinical trial.
Key words : Causal inference; Competing events; Effect decomposition; G-formula;
Hazard functions; Separable effects.
1. Introduction
Researchers are often interested in treatment effects on an event of interest that is
subject to competing events, that is, events that make it impossible for the event of in-
terest to subsequently occur. For example, when the event of interest is kidney injury,
death is a competing event because any individual who dies prior to kidney injury can-
not subsequently suffer from kidney injury. A counterfactual contrast in cause-specific
3cumulative incidences (risks) quantifies the total effect of the treatment on the event of
interest through all causal pathways. When the treatment affects competing events, the
total effect also partly includes pathways mediated by these competing events [1, 2]. For
example, a harmful total effect of blood pressure therapy on the risk of kidney injury
may be due to a biological side-effect on the kidneys, but could also be fully or partly
explained by a protective treatment effect on cardiovascular death.
As previously discussed [1, 2], other popular estimands in competing events settings do
not address this interpretational problem. Counterfactual contrasts in cause-specific or
subdistribution hazard ratios do not generally have a causal interpretation as they con-
trast counterfactual outcomes in different populations (those who survive under different
treatments). Other estimands that do have a causal interpretation may be of limited
practical relevance. Specifically, a counterfactual contrast in marginal cumulative inci-
dences (or net risks [3]) is a special case of a controlled direct effect [4], which is defined
relative to outcomes under an intervention to eliminate competing events. Alternatively,
the survivor average causal effect defines the total effect in the subset of the population
that would survive the competing event under any level of treatment. This subset, which
may not even exist, is never identified as it requires knowledge of cross-world treatment
conditions that are unobservable. Finally, pure (natural) direct and indirect effects [4, 5]
are defined relative to outcomes under interventions that assign individuals competing
event status under unobservable cross-world treatment conditions.
To address the shortcomings of these existing estimands, we recently proposed the sep-
arable effects for causal inference in competing event settings [6], inspired by Robins and
Richardson’s extended graphical approach to mediation analysis [7, 8]. Given a plausible
decomposition of the treatment into different components, we defined these effects as
counterfactual contrasts indexed by hypothetical interventions that assign these compo-
nents different values. The separable effects have clear advantages over the existing causal
estimands. In particular, the separable effects do not require hypothetical interventions
that eliminate competing events and avoid cross-world counterfactuals, which can never
4be subject to empirical scrutiny [7]. Instead, the separable effects can, at least in prin-
ciple, be directly identified in a future experiment where the treatment components are
assigned different values [6].
In Stensrud et al. [6], we defined separable effects under the special case where neither
treatment component affects common causes of the event of interest and the competing
event. In these settings, the separable effects can be interpreted as direct and indirect ef-
fects, quantifying treatment effects acting exclusively outside of, and exclusively through,
the competing event, respectively. We also formalized conditions under which the sepa-
rable effects can be identified in a study where the original treatment has not yet been
decomposed and only baseline covariates are measured.
In this paper, we extend the results of Stensrud et al. [6] in several ways. We define sep-
arable effects under a generalized treatment decomposition assumption, allowing settings
where the treatment components affect common causes of the event of interest and the
competing event. We describe the interpretation of separable effects in this more general
setting, where they may not exclusively quantify direct and indirect effects. We also give
weaker assumptions for identification of the separable effects, which not only depend on
measurements of baseline covariates, but also time-varying covariates. Finally we present
semi-parametric weighted estimators of the separable effects in these generalized settings.
The manuscript is organized as follows. In Section 2, we describe the observed data
structure in which the event of interest is subject to competing events and both baseline
and time-varying covariates are measured. In Section 3, we review the definition of
the total effect on an event of interest subject to competing events. In Section 4, we
define the generalized decomposition assumption that is agnostic to the mechanism by
which the treatment exerts effects on the competing event and the event of interest. In
Section 5, we formally define the separable effects. In Section 6, we formalize a range
of conditions by which the treatment components may exert effects on future outcomes
and explain the interpretation of the separable effects in each case. The most restrictive
of these conditions coincides with those considered by Stensrud et al. [6] under which
the separable effects can be interpreted as direct and indirect effects. In Section 7, we
5give conditions that allow identification of the separable effects under the observed data
structure by a particular g-formula [1]. In Section 8, we generalize identification results
to allow for censored data. In Section 9, we provide two weighted representations of the
g-formula for the separable effects and use these representations to motivate weighted
estimators, which are supplemented with sensitivity analysis techniques in Appendix G.
In Section 10, we apply these results to a randomized study of the effect of intensive
versus standard blood pressure therapy on acute kidney injury. In Section 11, we provide
a discussion.
2. Observed data structure
We consider an experiment in which i = 1, . . . , n individuals are randomly assigned
to one of two treatment arms A ∈ {0, 1} at baseline (e.g. A = 0 and A = 1 denote
assignment to standard and intensive blood pressure therapy, respectively). We assume
that observations are independent and identically distributed and suppress the i subscript.
Let k = 0, 1, 2, ..., K+1 be equally spaced time intervals with interval k = 0 corresponding
to baseline (the interval of randomization) and interval k = K+1 the maximum follow-up
of interest at or before the administrative end of follow-up (e.g. 60 months).
For k > 0, let Yk andDk denote indicators of an event of interest (e.g. kidney injury) and
a competing event (e.g. death) by interval k, respectively, and Lk a vector of individual
time-varying covariates in that interval. Define D0 ≡ Y0 ≡ 0, i.e. the population is
restricted to those alive and at risk of all events prior to randomization. Further, define
L0 as a vector of pre-randomization covariates. We denote the history of a random
variable by an overbar, e.g. Y¯k = (Y0, Y1, ..., Yk) is the history of the event of interest
through interval k, and the future of a random variable through K + 1 by an underline,
e.g. Y k = (Yk, Yk+1, ..., YK+1).
Throughout, we assume a temporal order (Dk, Yk, Lk) in each interval k > 0. Impor-
tantly, as interval lengths become arbitrarily small, this temporal order assumption is
guaranteed because the probability that two events of any type occur within that in-
terval approaches zero (equivalent to the common assumption in survival analysis of no
6tied event times). In this case, the time-varying event history DK+1, Y K+1 coincides with
the more familiar competing events data structure {T˜ = min(T,G), J} for T the time to
failure from any cause, G a censoring time and J an indicator of cause of failure such
that J = 0 when T˜ = G and J > 0 otherwise (e.g. J = 1 if failure from kidney injury
and J = 2 if failure from death). Defining the observed data structure in terms of time-
varying failure status, as opposed to the summarized (T˜ , J), is essential for understanding
identification and interpretation of many causal estimands in survival analysis, including
those considered here, and further avoids the assumption that there exists a censoring
time G for individuals who are observed to fail (e.g. die) during the follow-up [2].
By definition of a competing event, if an individual experiences this event by interval k
without history of the event of interest (Yk−1 = 0, Dk = 1) then Y k = 0; an individual who
experiences the competing event cannot subsequently experience the event of interest. For
ease of presentation, we will assume no individual is censored by loss to follow-up (that
is, DK+1, Y K+1 is fully observed for all individuals randomized at baseline) until Section
8.
3. The total treatment effect on the event of interest
For any individual in the study population and for k ∈ {0, . . . , K}, let Y ak+1 be the
indicator of the event of interest by interval k + 1 had, possibly contrary to fact, he/she
been assigned to A = a. The contrast
Pr(Y a=1k+1 = 1) vs. Pr(Y
a=0
k+1 = 1)(1)
is then a total effect of treatment A on the risk of the event of interest by interval k+1 in
this study population, which also may include treatment effects on the competing event
[2].
We will use causal directed acyclic graphs (DAGs) [5] to represent underlying assump-
tions on how random variables in the study of Section 2 are generated. A causal DAG
must represent all common causes of any variable represented on the DAG. For exam-
ple, the causal DAG in Figure 1a represents a generally restrictive assumption on this
7data generating process for a subset of time points because it depicts no common causes
(measured or unmeasured) of event status over time. Throughout we will assume that
causal DAGs represent a Finest Fully Randomized Causally Interpreted Structural Tree
Graph (FFRCISTG) model, a type of counterfactual causal model that generalizes the
non-parametric structural equation model with independent errors (NPSEM-IE) [1, 7, 5],
and we assume that statistical independencies in the data are faithful to the DAG [9].
The total effect of A on Y2 in Figure 1a includes all directed (causal) paths between
A and Y2. This includes causal paths that do not capture the treatment’s effect on the
competing event (e.g. A → Y1 → Y2 and A → Y2) as well as causal paths that capture
this effect (e.g. A → D1 → D2 → Y2 and A → D2 → Y2). While the total effect
can be straightforward to identify from a study in which A is randomly assigned, its
interpretation is complicated when pathways like A→ D2 → Y2 in Figure 1a are present
[2, 6]. For example, a harmful total effect of intensive versus standard blood pressure
therapy on kidney injury, i.e. Pr(Y a=1k+1 = 1) > Pr(Y
a=0
k+1 = 1), may be wholly or partially
explained by one of these pathways (e.g. a protective effect of intensive therapy on death).
4. Generalized decomposition assumption
Consider the following assumption:
Generalized decomposition assumption:
The treatment A can be decomposed into two binary
components AY ∈ {0, 1} and AD ∈ {0, 1} such that,
in the observed data, the following determinism holds
A ≡ AD ≡ AY , but in a future study, AY and AD
could, in principle, be assigned different values.(2)
Let Zk, k ∈ {0, . . . , K}, be the vector of all (direct or indirect) causes of Yk+1
and/or Dk+1, excluding (AY , AD), and Zj, j = 0, . . . , k are the values of these
8causes in interval j. We also assume that an intervention that assigns A = a
results in the same outcome as an intervention that assigns AY = AD = a, that
is,
Y aY =a,aD=ak+1 = Y
a
k+1
DaY =a,aD=ak+1 = D
a
k+1,
ZaY =a,aD=ak+1 = Z
a
k+1, k ∈ {0, . . . , K},(3)
where W aY ,aDk+1 for Wk+1 ∈ {Yk+1, Dk+1, Zk+1} k ∈ {0, . . . , K}, is the value of
Wk+1 had, contrary to fact, he/she been assigned the components AY = aY and
AD = aD, in place of assignment to a value of the original treatment A.
Beyond (3), the generalized decomposition assumption makes no mechanistic assump-
tions on the effects exerted by AY and AD. We will consider different examples of treat-
ment decompositions in Section 6. In Appendix A we consider straightforward further
generalizations of our results to settings where AY and AD are not a decomposition of A,
violating (2), but are still treatments satisfying (3).
5. Separable effects
Following Stensrud et al [6], for k ∈ {0, . . . , K},
(4) Pr(Y aY =1,aDk+1 = 1) vs. Pr(Y
aY =0,aD
k+1 = 1), aD ∈ {0, 1},
quantifies the causal effect of the AY component on the risk of the event of interest by
k + 1 under an intervention that assigns AD = aD. Similarly
(5) Pr(Y aY ,aD=1k+1 = 1) vs. Pr(Y
aY ,aD=0
k+1 = 1), aY ∈ {0, 1},
quantifies the causal effect of the AD component on the risk of the event of interest by
k + 1 under an intervention that assigns AY = aY .
We will refer to (4) as the AY separable effect under AD = aD, aD ∈ {0, 1} and (5) as
the AD separable effect under AY = aY , aY ∈ {0, 1}. Given the generalized decomposition
9assumption, the total effect can be expressed as a sum of particular AY and AD separable
effects, for example,
Pr(Y aY =1,aD=1k+1 = 1)− Pr(Y aY =0,aD=1k+1 = 1)
+ Pr(Y aY =0,aD=1k+1 = 1)− Pr(Y aY =aD=0k+1 = 1)
= Pr(Y a=1k+1 = 1)− Pr(Y a=0k+1 = 1).
6. Isolation conditions and interpretation of separable effects
In this section, we consider conditions, beyond the generalized decomposition assump-
tion, under which we can ascribe a more precise interpretation to the separable effects
(4) and (5). The strongest of these assumptions allows interpretation of these effects as
the separable direct and indirect effects of Stensrud et al [6]. To formally define these
additional conditions, we will first review the definition of an extended causal DAG [7]:
an extended causal DAG augments the original causal DAG with additional nodes rep-
resenting components of the treatment, and bold vertices representing the deterministic
relation between these components and the full treatment in the observed data. For ex-
ample, the extended causal DAG in Figure 1b is an augmented version of the causal DAG
in Figure 1a. The extended causal DAG also encodes assumptions, not represented on
the original causal DAG, on the mechanisms by which each treatment component exerts
effects on future variables.
The interpretation of the separable effects will also depend on the nature of Zk, k > 0
as defined in Section 4. We will remain agnostic until Section 7 as to whether all or some
of the components of Zk are measured or unmeasured in our study of Section 2. Therefore
the components of Zk may or may not partially or fully coincide with the components of
the measured covariate history Lk. As we will discuss in Section 7, the overlap (or lack
thereof) of Zk and Lk will impact our ability to identify the separable effects under the
observed data structure of Section 2.
6.1. Full isolation. Consider an extended causal DAG in which A is decomposed into
two components AY and AD satisfying the generalized decomposition assumption (3),
10
and define the following conditions:
The only causal paths from AY to Dk+1, k = 0, ..., K are directed
paths intersected by Yj, j = 0, ..., k.(6)
The only causal paths from AD to Yk+1, k = 0, ..., K are directed
paths intersected by Dj+1, j = 0, ..., k.(7)
When both conditions (6) and (7) hold we will say there is full isolation. This assumption
is satisfied in Figure 1b which assumes there are no common causes of the event of interest
and the competing event. It is also satisfied in Figure 2b which allows the presence of
both pre-randomization (Z0) and post-randomization (Z1) common causes.
Under the generalized decomposition assumption and full isolation, (4) are the separa-
ble direct effects of A on the risk of the event of interest by k + 1, which do not capture
the treatment’s effect on the competing event, and (5) are the separable indirect effects
of A on this risk, which only capture the treatment’s effect on the competing event. Full
isolation coincides with the settings considered by Stensrud et al [6], which allowed for
the presence of pre-randomization, but not post-randomization, common causes of the
event of interest and the competing event.
Returning to our running example, assume that the blood pressure treatment A can be
decomposed into a component AY that binds to receptors in the kidneys, e.g. by relaxing
the efferent arterioles which is a well-known biological effect of commonly used blood
pressure drugs such as angiotensin-converting-enzyme inhibitors (ACE) and angiotensin
II receptor blockers (ARB), and a component AD that includes the remaining components
of the antihypertensive therapy, some of which lead, for example, to reductions in systemic
blood pressure.
Then, AY = 1 and AY = 0 are the levels (doses) of the AY component under standard
and intensive therapy, respectively, and AD = 1 and AD = 0 are defined analogously.
Full isolation would be satisfied in this case if (i) the AY component only exerts effects
on death through its effects on kidney function and (ii) the remaining AD component only
11
exert effects on kidney function through its effects on survival. In Section 6.2, however,
we argue that the assumption of full isolation may not be reasonable in this setting.
6.2. AY partial isolation. The causal graphs in Figures 1 and 2 make the restrictive
assumption that there are no common causes of the event of interest and competing event
that are, themselves, affected by treatment. In our running example, this assumption
likely fails: a reduction in blood pressure may increase the risk of kidney injury (the
event of interest) due to hypoperfusion of the kidneys (for example, when patients are
dehydrated) [10] and also may affect the risk of mortality (the competing event). Further,
blood pressure itself clearly may be affected by the blood pressure treatment. The causal
DAG in Figure 3 depicts the more realistic assumption that blood pressure (Z1) is both
a possible common cause of future kidney injury Y2 and mortality D2 and also, itself,
affected by treatment A (represented by the blue arrow connecting A to Z1).
Suppose, however, that the AY component of the treatment A (that which binds to
receptors in the kidneys) has no effect on blood pressure outside of its possible effect on
kidney function, such that only the remaining components of treatment, AD, can directly
affect blood pressure. The extended DAG in Figure 4a, which is one possible extension
of the causal DAG in Figure 3, represents this assumption by the blue arrow from AD
into Z1 and the absence of an arrow from AY into Z1. In this case, condition (6) holds
but (7) does not. When only the condition (6) holds, but (7) fails, we will say there is
AY partial isolation.
Unlike under full isolation, under AY partial isolation, the AD separable effects (5)
quantify both direct effects of the treatment on the event of interest not through the
competing event (e.g. the path AD → Z1 → Y2 in Figure 4a) and indirect effects through
the competing event (e.g. the path AD → D1 → Y1 → Y2 in Figure 4a). By contrast, the
AY separable effects only quantify direct effects not through the competing event. How-
ever, the AY separable effects do not capture all direct effects in this case, because some
of these pathways may originate from AD as described above. In the current example, the
AY separable effect evaluated at aD = 1 may be of particular clinical interest, quantifying
12
the effect of assignment to the current intensive therapy containing all components versus
a modified intensive therapy that lacks the component possibly affecting the kidneys.
6.3. AD partial isolation. When (7) holds, but (6) fails, we will say there is AD par-
tial isolation. AD partial isolation is represented in Figure 4b, depicting an alternative
augmentation of the causal DAG in Figure 3. Under AD partial isolation, the AY sepa-
rable effects (4) quantify both direct effects of the treatment on the event of interest not
through the competing event (e.g. the path AY → Z1 → Y2 in Figure 4b) and indirect
effects through the competing event (e.g. the path AY → Z1 → D2 → Y2 in Figure 4b).
By contrast, the AD separable effects only quantify indirect effects through the compet-
ing event. However, the AD separable effects do not capture all indirect effects in this
case, because some of these pathways may originate from AY as above.
As an example of AD partial isolation, trials have reported an increase in the risk of
new-onset type 2 diabetes among patients assigned to statins [11, 12]. However, statins
also reduce the risk of all-cause mortality, a competing event for type 2 diabetes onset
(the event of interest). It is therefore unclear whether a total effect of statin treatment on
type 2 diabetes is due a protective treatment effect on mortality, a biologically harmful
process leading to type 2 diabetes onset or some combination.
Figure 3 illustrates a possible underlying causal structure for a trial with random
assignment to statin therapy relating treatment assignment A, mortality Dk and new-
onset type 2 diabetes Yk, k = 1, 2. Body weight (Z1) is a possible common cause of both
mortality and onset of type 2 diabetes which may also be affected by statin treatment.
Consider a decomposition of A (represented in Figure 4b) where AD may lead to increased
risk of diabetes only by reducing mortality risk (e.g. throughAD → D1 → D2 → Y2, where
the reduction in mortality risk is likely due to reduced levels of low density lipoprotein in
the blood), while a second component AY exerts unintended effects of statins on diabetes
through body weight (e.g. through AY → Z1 → Y2). As in the previous example of blood
pressure therapy and kidney injury, the AY separable effect of statin therapy on type 2
diabetes risk evaluated at aD = 1 may be of particular clinical interest, quantifying the
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effect of assignment to the original statin therapy containing both components versus a
modified treatment that removes the component possibly leading to weight gain.
6.4. No isolation. If there are direct arrows from AY and AD into common causes of
Yk+1 and Dk+1, k ∈ {0, . . . , K}, as illustrated in Figure 5, then both (6) and (7) fail. In
this case, both the AY separable effects (4) and the AD separable effects (5) quantify direct
and indirect effects of the treatment on the event of interest, outside of and through, the
competing event. When both conditions (6) and (7) fail, we will say there is no isolation.
There are two important cases of no isolation that have different implications for the
interpretation of separable effects and, as we will see, their identification in a two-arm
trial. First, suppose there are direct arrows from AY and AD into the same set of common
causes Zk of Y k+1 and Dk+1, as illustrated in Figure 5a. In this case, the AY separable
effects and the AD separable effects will capture common downstream pathways (e.g.
Z1 → Y2 in Figure 5a) between the original treatment A and the event of interest Yk+1.
Alternatively, suppose AY and AD may only exert effects on different sets of common
causes ZAY ,1 and ZAD,1 of Yk+1 and Dk+1 as illustrated in Figure 5b; here AY exerts
effects on Yk+1 through one set of causal paths from AY to Yk+1, and AD exerts effects on
Yk+1 through a distinct set of causal paths. In this case, the AY separable effects and the
AD separable effects will capture no common pathways between the original treatment
A and the event of interest Yk+1.
6.5. Zk partition. Suppose there exist vectors ZAD,k, ZAY ,k such that Zk ≡ (ZAD,k, ZAY ,k),
k > 0, and
The only causal paths from AY to Dk+1 and ZAD,k+1, k = 0, ..., K are through
Yj or any component of ZAY ,j, j = 0, ..., k.(8)
The only causal paths from AD to Yk+1 and ZAY ,k+1, k = 0, ..., K are through
Dj+1 or any component of ZAD,j, j = 0, ..., k.(9)
When both conditions (8) and (9) hold we will say there is a Zk partition.
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The assumption of a Zk partition holds trivially under full isolation for any partition
of Zk as illustrated in Figure 2b. However, this assumption will only hold in some cases
of partial isolation (e.g. Figure 4) and no isolation (e.g. Figure 5b). Zk partition fails
under the case of no isolation represented in Figure 5a. It also fails under the case of AY
partial isolation represented in Figure 6a and AD partial isolation represented in Figure
6b. Under any version of Zk partition, the AY separable effects and the AD separable
effects will capture no common pathways between the original treatment A and the event
of interest Yk+1.
7. Identification of separable effects
Regardless of the isolation assumptions that impact the interpretation of separable
effects, if we had data from a four-arm trial in which AY and AD were randomly assigned
with no loss to follow-up, we would be guaranteed identification of the separable effects
[6, 13]; that is, we could identify, for k ∈ {0, . . . , K},
Pr(Y aY ,aDk+1 = 1) for aY , aD ∈ {0, 1}(10)
by Pr(Yk+1 = 1 | AY = aY , AD = aD) [14]. However, in order to identify (10) for aY 6= aD
in the absence of a four-arm trial, we must make untestable assumptions that are not
guaranteed to hold, even in a two-armed trial such as that described in Section 2 with
no loss to follow-up. In addition to the generalized decomposition assumption, consider
the following assumptions:
1. Exchangeability:
Y a1, D
a
1, L
a
1 ⊥ A | L0.(11)
Exchangeability is expected to hold in a study where A is randomly assigned,
possibly conditional on the measured baseline covariates L0, but is otherwise not
guaranteed to hold [14]. For example, Figure 7 illustrates various extended graphs
that explicitly depict measured (e.g. L1) and unmeasured (e.g. UL,Y ) variables.
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Exchangeability is represented in Figures 7a-f by the absence of any unblocked
backdoor paths between A and (Y 1, D1, L1) conditional on L0 [5].
2. Consistency:
If A = a,
then Y¯k+1 = Y¯
a
k+1, D¯k+1 = D¯
a
k+1 and L¯k+1 = L¯
a
k+1 for k ∈ {0, . . . , K}.(12)
Consistency states that if an individual has observed treatment consistent with
an intervention that sets A = a, then that individual’s future observed outcomes
and time-varying covariates are equal to his/her counterfactual outcomes and
time-varying covariates, respectively, under an intervention that sets A = a. Con-
sistency holds in a study where A is randomly assigned but is otherwise not
guaranteed.
3. Positivity:
fL0(l0) > 0 =⇒
Pr(A = a | L0 = l0) > 0, for a ∈ {0, 1}(13)
fLk,Dk+1,Yk(lk, 0, 0) > 0 =⇒
Pr(A = a|Dk+1 = Yk = 0, Lk = lk) > 0,
for a ∈ {0, 1} and k ∈ {0, . . . , K}.(14)
Assumption (13) states that, for any possibly observed level of the measured
baseline covariates, there exist individuals with A = 1 and individuals with A = 0.
This assumption will hold by design in a randomized controlled trial like that of
Section 2. Assumption (14) requires that for any possibly observed level of the
measured time-varying covariate history among those surviving all events through
each follow-up time, there exist individuals with A = 1 and individuals with
A = 0. Even when A is randomized, assumption (14) does not hold by design.
However, it can be assessed in the observed data.
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4. Dismissible component conditions:
LetG refer to a hypothetical four-arm trial in which both AY and AD are randomly
assigned, possibly to different values. We define the following conditions for k ∈
{0, . . . , K}:
Yk+1(G) ⊥ AD(G) | AY (G), Dk+1(G) = Yk(G) = 0, L¯k(G),(15)
Dk+1(G) ⊥ AY (G) | AD(G), Dk(G) = Yk(G) = 0, L¯k(G),(16)
LAY ,k(G) ⊥ AD(G) | AY (G), Yk(G) = Dk(G) = 0, L¯k−1(G), LAD,k(G),(17)
LAD,k(G) ⊥ AY (G) | AD(G), Dk(G) = Yk(G) = 0, L¯k−1(G),(18)
where Yk+1(G), Dk+1(G) and Lk(G) ≡ (LAY ,k(G), LAD,k(G)) are values of the out-
come of interest, the competing outcome and (a temporally ordered partitioning
of) the measured covariates at k + 1, respectively, had we, contrary to fact, ran-
domly assigned AY (G) and AD(G), the values of AY and AD assigned an individ-
ual under G, respectively. It follows directly from the generalized decomposition
assumption that, using d-separation rules [7, 5], the dismissible component condi-
tions can be read off of a transformation of the extended causal DAG, representing
an augmented version of our original data generating assumption, in which A and
the deterministic arrows originating from A are eliminated. See similar results in
Didelez [8, Figure 2].
For example, consider Figure 8a, a transformation of Figure 4a, which assumes
that Lk ≡ Zk, (i.e., all common causes of the event of interest and competing
event are measured). Assumption (15) holds in Figure 8a by the absence of
any unblocked backdoor paths between AD(G) and Y2(G) conditional on AY (G),
D1(G), D2(G), L1(G) and Y1(G), and similarly assumption (16) holds due to the
absence of any unblocked paths between AY (G) and D2(G) conditional on AD(G),
D1(G), L1(G) and Y2(G). Analogously, by choosing Lk(G) = (LAY ,k(G), ∅), k =
1, 2, (17) and (18) also hold in Figure 8a.
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Consider also the examples in Figure 7; under G transformations of each graph,
all dismissible component conditions hold in Figures 7a-d, where LAD,1 = L1 and
LAY ,1 = ∅ in Figures 7a-c. By contrast, Figures 7e-f illustrate failure of these
conditions under their G transformations. For example, while (16)-(18) hold in
Figure 7e, (15) is violated by the the unblocked collider path AD(G)→ D2(G) ←
UL,D → L1(G) ← UL,Y → Y2(G), regardless of whether we define LAD,1 = L1 and
LAY ,1 = ∅ or LAY ,1 = L1 and LAD,1 = ∅. Similarly, in Figure 7f, while (16)-(18)
hold when we define LAD,1 = L1 and LAY ,1 = ∅, (15) is violated by the unblocked
collider path AD(G)→ L1(G) ← UL,Y → Y2(G).
7.1. Relation between isolation and dismissible component conditions. Note
that Zk partition is a necessary condition for the dismissible component conditions to
hold for any choice of measured covariates Lk and their partition (see proof in Appendix
C). However, Zk partition is not sufficient to ensure these conditions as also illustrated
by Figure 7. For example, in Figure 7e, full isolation holds but, as we noted above, the
dismissible component conditions fail due to failure to measure either the common cause
UL,D or UL,Y . Similarly, the graph in Figure 7f satisfies Zk partition, but, as we noted
above, the dismissible component conditions fail due to failure to measure the common
cause UL,Y . These results on identification and those of the previous section coincide
with previous identification results on identification of path-specific effects [15, 16] but
without explicit consideration of competing events.
In Appendix C we also show that: (i) if the dismissible component conditions hold
when we select the Lk partition LAD,k = Lk and LAY ,k = ∅ for all k ∈ {1, . . . , K}, then
AY partial isolation holds; (ii) if the dismissible component conditions hold when we
select the Lk partition LAY ,k = Lk and LAD,k = ∅ for all k ∈ {1, . . . , K}, then AD partial
isolation holds; and (iii) if the dismissible component conditions hold when we select
either of the partitions in (i) and (ii) then full isolation holds and Lk does not depend on
A at any k, given the measured past.
Note that we may consider a decomposition of A into more than two components
under a stronger version of the generalized decomposition assumption (Appendix E).
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Then we can define alternative versions of separable effects indexed by interventions
that may assign different values to these components. Under failure of Zk partition for
a two-way decomposition, identification may be possible for separable effects indexed
by multiple components but under additional assumptions. We briefly consider these
alternative definitions of separable effects and their identification for the case of a three-
way decomposition of A in Appendix E.
7.2. The g-formula for separable effects. For k ∈ {0, . . . , K}, let lk = (lAy ,k, lAD,k)
be a realization of the measured time-varying covariates at k, such that lAY ,k and lAD,k
are possible realizations of LAy ,k and LAD,k, respectively (a chosen partition of Lk under
an assumed temporal order LAD,k, LAY ,k). Provided that exchangeability, consistency,
positivity and the 4 dismissible component conditions hold, we can identify Pr(Y aY ,aDk+1 =
1) by
∑
l¯k
[ k∑
s=0
Pr(Ys+1 = 1 | Ds+1 = Ys = 0, L¯s = l¯s, A = aY )
s∏
j=0
{
Pr(Dj+1 = 0 | Dj = Yj = 0, L¯j = l¯j, A = aD)
× Pr(Yj = 0 | Yj−1 = Dj = 0, A = aY )
× Pr(LAY ,j = lAY ,j | Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
× Pr(LAD,j = lAD,j | Yj = Dj = 0, l¯j−1, A = aD)
}]
,(19)
k ∈ {0, . . . , K} where, generally, for any vector of random variables A and B, f(a|b) ≡
fA|B(a|b) is the joint density of A given B evaluated at a, b. See Appendix B for proof.
We will refer to expression (19) as the g-formula [1] for Pr(Y aY ,aDk+1 = 1).
8. Censored data
We now relax the assumption of no losses to follow-up, allowing that some individuals
are censored at some point during the study. For k > 0, let Ck denote censoring by loss
to follow-up by interval k, and assume a temporal order (Ck, Dk, Yk, Lk) in each interval
k > 0. We remind the reader that the the temporal ordering assumption is analogous to
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assumptions about ties in continuous time settings, which becomes practically irrelevant
when the time intervals are small. Hereby, we will implicitly redefine all counterfactual
outcomes Y aY ,aDk+1 in terms of outcomes under an additional intervention that eliminates
censoring.
When censoring is present, the isolation conditions defined in Section 6 and their im-
plications for interpretation of separable effects are unchanged. However, in this case,
additional exchangeability, positivity and consistency assumptions are required for iden-
tification of (10) using only the observed data. Given assumptions (26)-(35) in Appendix
B, which extend the assumptions of Section 7 to allow that censoring is present and
dependent on the measured time-varying risk factors Lk, we can identify (10) by
∑
l¯k
[ k∑
s=0
Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s = l¯s, A = aY )
s∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aD)
× Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j = l¯j, A = aY )
× f(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
× f(LAD,j = lAD,j | Cj = Yj = Dj = 0, Lj−1 = l¯j−1, A = aD)
}]
.(20)
See Appendix B for proof. We say expression (20) is the g-formula for (10) under elimi-
nation of censoring. When assumptions (26)-(35) hold replacing Lk = L0, k ∈ {0, . . . , K}
then identification of (10) is achieved by a simplified version of (20) which was given in
Stensrud et al [6].
9. Estimation of separable effects
The g-formula (20) has the following alternative representations,
k∑
s=0
E[WC,s(aY )WD,s(aY , aD)WLAD ,s(aY , aD)(1− Ys)(1−Ds+1)Ys+1 | A = aY ],(21)
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where
WD,s(aY , aD) =
∏s
j=0 Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j, A = aD)∏s
j=0 Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j, A = aY )
,
WLAD ,s(aY , aD) =
∏s
j=0 Pr(A = aD | Cj = Yj = Dj = 0, LAD,j, L¯j−1)∏s
j=0 Pr(A = aY | Cj = Yj = Dj = 0, LAD,j, L¯j−1)
×
∏s
j=0 Pr(A = aY | Cj = Yj = Dj = 0, L¯j−1)∏s
j=0 Pr(A = aD | Cj = Yj = Dj = 0, L¯j−1)
,
WC,s(aD) =
I(Cs+1 = 0)∏s
j=0 Pr(Cj+1 = 0 | Cj = Dj = Yj = 0, L¯j, A = aD)
,
and
k∑
s=0
E{WC,s(aD)WY,s(aD, aY )WLAY ,s(aD, aY )(1− Ys)(1−Ds+1)Ys+1 | A = aD},(22)
where WC,s(aD) is defined as in (21) and
WY,s(aD, aY ) =
Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s, A = aY )
Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s, A = aD)
×
∏s−1
j=0 Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j, A = aY )∏s−1
j=0 Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j, A = aD)
,
WLAY ,s(aD, aY ) =
∏s
j=0 Pr(A = aY | Cj = Yj = Dj = 0, L¯j)∏s
j=0 Pr(A = aD | Cj = Yj = Dj = 0, L¯j)
×
∏s
j=0 Pr(A = aD | Cj = Yj = Dj = 0, LAD,j, L¯j−1)∏s
j=0 Pr(A = aY | Cj = Yj = Dj = 0, LAD,j, L¯j−1)
,
as formally shown in Appendix D.
Representations (21) and (22) motivate weighted estimators of the separable effects,
which generalize the weighted estimators given by [6]. We let νaY ,aD,k denote (20), and
(Lk,i, LAD,k,i) is study individual i’s values of (Lk, LAD,k) for a user-chosen partition of
Lk.
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Define
WˆD,k,i(aY , aD; αˆD) =
∏k
j=0 Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j,i, A = aD; αˆD)∏k
j=0 Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j,i, A = aY ; αˆD)
,
WˆLAD ,k,i(aY , aD; αˆLD1, αˆLD2) =
∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, LAD,j,i, L¯j−1,i; αˆLD1)∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, LAD,j,i, L¯j−1,i; αˆLD1)
×
∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, L¯j−1,i; αˆLD2)∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, L¯j−1,i; αˆLD2)
,
WˆC,k,i(aD; αˆC) =
I(Ck+1 = 0)∏k
j=0 Pr(Cj+1 = 0 | Cj = Dj = Yj = 0, L¯j,i, A = aD; αˆC)
,
where Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j, A = aD;αD) is a parametric model for
the numerator (and denominator) of WD,k(aY , aD) indexed by parameter αD, and αˆD is a
consistent estimator of αD (e.g. the MLE). The terms in WˆLAD ,k,i(aY , aD; αˆLD1, αˆLD2) and
WˆC,k,i(aD; αˆC) are defined analogously, where αˆLD1, αˆLD2, αˆC are consistent estimators of
corresponding model parameters αLD1, αLD2, αC , respectively.
Let α1 = (αD, αLD1, αLD2, αC), and define the estimator νˆ1,aY ,aD,k of νaY ,aD,k as the
solution to the estimating equation
∑n
i=1 U1,k,i(νaY ,aD,k, αˆ1) = 0 with respect to νaY ,aD,k
with
U1,k,i(νaY ,aD,k, αˆ1)
=I(Ai = aY )
[ k∑
s=0
{Wˆ1,s,i(aY , aD; αˆ1)Ys+1,i(1− Ys,i)(1−Ds+1,i)} − νaY ,aD,k
]
,
and Wˆ1,s,i(aY , aD; αˆ1) = WˆD,s,i(aY , aD; αˆD)WˆLAD ,s,i(aY , aD; αˆLD1, αˆLD2)WˆC,s,i(aY ; αˆC).
Provided that the models indexed by elements in α1 are correctly specified and αˆ1 is a
consistent estimator for α1, then consistency of νˆ1,aY ,aD,k for νaY ,aD,k follows because (20)
and (21) are equal. We describe an implementation algorithm for νˆ1,aY ,aD,k in Appendix
F. In practice, we can use popular regression models for binary outcomes to estimate
the weights WD,k(aY , aD) and WC,k(aY ). However, when we parameterize the terms in
WˆLAD ,k(aY , aD; αˆLD1, αˆLD2), we must ensure that the statistical models are congenial,
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which may fail for popular models, such as logistic regressions models. In Appendix D,
we have provided an alternative expression of WLAY ,k(aY , aD) that motivates different
weighted estimators based on estimation of the conditional joint densities of Lk. These
alternative weighted estimators avoid the problem of incongenial models at the expense
of the need to model higher dimensional quantities.
The estimator based on (22) is derived analogously to the estimator based on (21).
Suppose
WˆY,k,i(aD, aY ; αˆY ) =
Pr(Yk+1 = 1 | Ck+1 = Dk+1 = Yk = 0, L¯k,i, A = aY ; αˆY )
Pr(Yk+1 = 1 | Cj+1 = Dk+1 = Yk = 0, L¯k,i, A = aD; αˆY )
×
∏k−1
j=0 Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j,i, A = aY ; αˆLY 1)∏k−1
j=0 Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j,i, A = aD; αˆLY 1)
,
WˆLAY ,k,i(aD, aY ; αˆLY 1, αˆLY 2) =
∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, L¯j,i; αˆLY 2)∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, L¯j,i; αˆLY 2)
×
∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, LAD,j,i, L¯j−1,i; αˆC)∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, LAD,j,i, L¯j,i; αˆC)
,
where the terms in WˆY,k,i(aD, aY ; αˆY ), WˆLAY ,k,i(aD, aY ; αˆLY 1, αˆLY 2) are statistical models
for binary outcomes, and where αˆY , αˆLY 1, αˆLY 2 are consistent estimators for αY , αLY 1, αLY 2,
respectively. Similar to WˆLAD ,k,i(aY , aD; αˆLD1, αˆLD2), however, we must ensure that con-
genial models are used to estimate the terms in WˆLAY ,k,i(aD, aY ; αˆLY 1, αˆLY 2).
Let α2 = (αY , αLY 1, αLY 2, αC), and define the estimator νˆ2,aY ,aD,k of νaY ,aD,k as the
solution to the estimating equation
∑n
i=1 U2,k,i(νaY ,aD,k, αˆ2) = 0 with respect to νaY ,aD,k,
where
U2,k,i(νaY ,aD,k, αˆ2)
=I(Ai = aD)
[ k∑
s=0
{Wˆ2,s,i(aY , aD; αˆ2)Ys+1,i(1− Ys,i)(1−Ds+1,i)} − νaY ,aD,k
]
,
and Wˆ2,s,i(aY , aD; αˆ2) = WˆC,s,i(aD; αˆC)WˆY,s,i(aD, aY ; αˆY )WˆLAY ,s,iaD, aY ; αˆLY 1, αˆLY 2). Anal-
ogous to the estimator based on (21), provided that the models indexed by elements in
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α2 are correctly specified and αˆ2 is a consistent estimator for α2, then consistency of
νˆ2,aY ,aD,k for νaY ,aD,k follows because (20) and (22) are equal.
9.1. Simplified estimators under assumptions on Lk. Given a user-chosen partition
of Lk such that LAY ,k ≡ Lk, LAD,k ≡ ∅ for k = 0, . . . , K, then WLAD ,k(aY , aD) = 1 and the
consistency of νˆ1,aY ,aD,k only requires consistent estimation of the weights WD,k(aY , aD)
and WC,k(aY ). Similarly, the partition LAD,k ≡ Lk, LAY ,k ≡ ∅ gives WLAY ,k(aD, aY ) = 1,
such that the consistency of νˆ2,aY ,aD,k only relies on consistent estimation of the weights
WY,k(aY , aD) and WC,k(aD). Of course, these simplified Lk partitions are only justified if
they satisfy the dismissible component conditions. As discussed in Section 7.1, identifi-
cation under these simplified Lk partitions implies partial or full isolation, impacting the
interpretation of the separable effects.
10. Data example: blood pressure therapy and acute kidney injury
As an illustration, we analyzed data from the Systolic Blood Pressure Intervention Trial
(SPRINT) [17], which randomly assigned individuals to intensive (A = 1) or standard
(A = 0) blood pressure treatment. We used follow-up data from each month k + 1,
k = 0 . . . , 29 and restricted our analysis to participants aged older than 75 years at
baseline in whom the most deaths (competing events) occurred [18]. For simplicity, we
further restricted to those patients with complete data on baseline covariates (described
below). This resulted in a data set with 1304 and 1297 in the intensive (A = 1) and
standard (A = 0) blood pressure therapy arms, respectively. During the 30-month follow-
up period, 107 and 98 of these patients were lost to follow-up (censored) in some month
k + 1 ≤ 30 in the intensive and standard arms, respectively.
In order to adjust for informative censoring by loss to follow-up, we used inverse proba-
bility of censoring weighted Aalen-Johansen estimators [19, 2] to estimate the total effects
of treatment assignment on the cause-specific cumulative incidences at each k+ 1 of kid-
ney injury and mortality. We adjusted for the baseline covariates (L0) smoking status,
history of clinical or subclinical cardiovascular disease, clinical of subclinical chronic kid-
ney disease, statin use and gender as well as the time-varying covariates (Lk) defined by
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the most recent measurements of systolic and diastolic blood pressure, scheduled monthly
for the first 3 months and every 3 months thereafter. The weight denominators were es-
timated under the following pooled logistic model for the probability of being censored
within each month k + 1 given the measured past,
logit{Pr(Ck+1 = 1 | Dk = Yk = C¯k = 0, A, L¯k)} = αC,0,k+1 + αC,1A+ αC,2Ak + α′C,1L0 + α′C,2Lk,
(23)
where αC,0,k+1 are time-varying intercepts modeled as 3rd degree polynomials. For all
analyses, 95% percent confidence intervals were constructed using 500 nonparametric
bootstrap samples.
The estimated cumulative incidence of acute kidney injury (the event of interest) under
the intensive treatment assignment was consistently higher compared to standard treat-
ment assignment (Figure 9a, solid lines), in line with a harmful total effect on acute kidney
injury. Specifically, the total effect estimate (on the additive scale) of intensive therapy
assignment versus standard was 0.01 (95% CI: [0.00, 0.03]) at 30 months of follow-up. As
discussed in Section 3, this harmful effect is hard to interpret due to a possible protective
effect of intensive treatment assignment on death (the competing event). This concern
is not easily ruled out by the data; the cumulative incidence of death under intensive
treatment assignment is consistently slightly lower compared to standard treatment as-
signment over the 30-month follow-up with differences increasing at 25 months, as shown
with dashed lines in Figure 9a. At 30 months, the total effect estimate on mortality was
-0.01 (95% CI: [−0.03, 0.00]).
As discussed in Section 6.2, for AY defined as the component of treatment A that
may exert biological effects on the kidneys, e.g. by relaxing the efferent arterioles, and
AD defined as all remaining components of A, AY partial isolation may be a reasonable
assumption given background subject matter knowledge. Under this assumption, the AY
separable effect (4) evaluated at aD = 1 does not capture effects of the treatment on the
competing event. It also may be of clinical interest as it quantifies the effect of removing
the possibly harmful AY component from the original treatment A.
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We used the inverse probability weighted estimator νˆ2,aY ,aD,k from Section 9 to estimate
(10) and, in turn, the AY separable effect (4) evaluated at aD = 1 on acute kidney injury at
each k+ 1 under the assumption that the measured baseline and time-varying covariates
are sufficient to ensure identification, including the dismissible component conditions
(15)-(18) under the partitioning Lk = LAD,k. This assumption, at best, approximately
holds because Lk contains only intermittent measurements of systolic and diastolic blood
pressure.
We estimated WY,k(aY , aD) under the pooled logistic models
logit{Pr(Yk+1 = 1 | Dk+1 = Yk+1 = C¯k+1 = 0, A = 0, L¯k)}
= αY,0,k+1 + α
′
Y,1L0 + α
′
Y,2Lk + α
′
Y,3L
2
k + α
′
Y,4Lkk,
logit{Pr(Yk+1 = 1 | Dk+1 = Yk+1 = C¯k+1 = 0, A = 1, L¯k)}
= αY,5,k+1 + α
′
Y,6L0 + α
′
Y,7Lk + α
′
Y,8L
2
k + α
′
Y,9Lkk,
(24)
for k = 0, . . . , 20, where αY,0,k+1 and αY,5,k+1 are time-varying intercepts modeled as 3rd
degree polynomials. The inverse probability of censoring weights WC(aD) were estimated
under (23).
Figure 9b shows estimates of the counterfactual cumulative incidence for acute kidney
injury under assignment to different combinations of aY and aD over time. The vertical
distance between the black and the green line at k+ 1 is a point estimate of the additive
AY separable effect when aD = 1 at that time, and similarly the vertical distance between
the red and the green line is the AD separable effect when aY = 0. In particular, the
estimated AY separable effect of 0.00 (95% CI: [−0.10, 0.02]) at k+ 1 = 30 months when
aD = 1, suggests that removing the AY component from the intensive therapy will not
decrease the average risk of kidney injury by 30 months. R code is provided in the
supplementary materials.
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11. Discussion
We have provided generalized results for interpretation and identification of separa-
ble effects in competing events settings. These results allow the separable effects to be
identified and meaningfullly interpreted in much broader settings than those initially
considered by Stensrud et al [6]. Generally these effects clarify the interpretation of to-
tal effects when competing events are affected by treatment, provide more information
to patients and doctors for current treatment decisions and inform the development of
improved treatments with unwanted components removed. In general, our framework
provides a basis for which subject matter experts can formally reason about the mecha-
nisms by which treatments act on time-to-event outcomes and subsequently falsify this
reasoning in a future trial.
Even under our generalized conditions, the separable effects may be difficult to identify
given currently available data in many studies. However, they can point to shortcomings
of the data typically collected in studies of competing events, and may guide the planning
for improved data collection in future studies.. This is particularly true of randomized
trials which have historically relied heavily on the treatment randomization; failing to
collect data on baseline and time-varying covariates makes it nearly impossible to adjust
for selection bias due to censoring and/or to target estimands other than the total effect
of the randomization. Furthermore, we outlined strategies for sensitivity analysis to both
the dismissible component conditions and isolation conditions in Appendix G.
We have focused on establishing fundamental results for interpretation and identifica-
tion of separable effects, as well as suggesting three estimators that are easy to implement.
In future work, we aim to derive new estimators from the efficient influence function,
which can achieve parametric convergence rates even when machine learning methods
are used for model fitting [20, 21, 22, 23], such that e.g. bias-aware model selection can
be performed to minimize bias due to model misspecification [24]. We will also extend our
results to separable effects of time-varying treatment interventions in competing events
settings, including per-protocol effects in trials with nonadherence.
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Figure 1. The directed acyclic graph (DAG) in (a) represents a restric-
tive data generating assumption on the observed data structure such that
there are no common causes of the event of interest and the competing
event at any time. The extended DAG in (b) is an augmented version of
the graph in (a) representing a treatment decomposition satisfying the gen-
eralized decomposition assumption. The bold arrows encode deterministic
relationships.
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(b)
Figure 2. The causal DAG in (a) allows a pre-randomization common
cause (Z0) of Y 1 and D1 and post-randomization common cause (Z1) of Y2
and D2 but assumes Z1 is not affected by treatment A. (b) is an extension
of (a) satisfying full isolation.
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Z1Z0
Figure 3. A causal DAG representing the assumption that Z1, a common
cause of Y2 and D2, may be affected by treatment A (blue arrow).
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(b)
Figure 4. Extensions of the causal DAG in Figure 3 illustrating partial
isolation. The blue arrow in (a) represents the A→ Z1 relation in Figure 3
under AY partial isolation, and the blue arrow in (b) represents AD partial
isolation.
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Figure 5. Causal graphs illustrating no isolation. (a) violates Zk partition
while (b) satisfies Zk partition.
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Figure 6. Causal graphs illustrating partial isolation but violation of Zk
partition. AY partial isolation holds in (a) and AD partial isolation holds
in (b).
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Figure 7. Extended graphs that explicitly depict measured and unmea-
sured variables. The dismissible component conditions are violated in (e)-
(f).
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AY (G)
AD(G)
Y1(G)
D1(G)
Y2(G)
D2(G)
L1(G)
(a)
AY (G)
AD(G)
Y1(G)
D1(G)
Y2(G)
D2(G)
LAY ,1(G)
LAD,1(G)
(b)
Figure 8. The graph in (a) is a successive transformation of Figure 4a
for L1 = Z1 that represents a hypothetical trial G in which both AY and
AD are randomly assigned. The graph in (b) is a transformation of Figure
5b, in which LAY ,1(G) ≡ ZAY ,1(G), LAD,1(G) ≡ ZAD,1(G). All dismissible
component conditions hold in both graphs.
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Figure 9. (a) Weighted Aalen-Johansen estimates of the cumulative inci-
dence functions for acute kidney injury (AKI, solid lines) and death (dashed
lines) under intensive (a = 1, red) and standard (a = 0, black) treat-
ment. (b) Estimates of AKI cumulative incidence based on methods of
Section 9 under a modified treatment containing only the AD component
(aD = 1, aY = 0, green). Cumulative incidence estimates under the original
intensive (a = aY = aD = 1, red) and the standard (a = aY = aD = 0,
black) of (a) are overlaid.
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Appendix A. Modified treatment assumption
To define the generalized decomposition assumption in Section 4, we considered a
decomposition of treatment A into different components, AY and AD, satisfying (2).
Yet, a physical decomposition of A into components AY and AD is not necessary for the
validity of our results on identification and estimation of separable effects in Sections
7-9. Specifically, the proofs in Appendix B only require condition (3) of the generalized
decomposition assumption, which may also hold for treatments AY and AD that are not
components of A.
In this case, the separable effects can still be meaningfully interpreted as the effects
of joint assignment to alternative treatments AY and AD in place of assignment to A.
The isolation conditions of Section 6 still constitute additional mechanistic assumptions
on how these alternative treatments operate on the event of interest and the competing
event, as defined relative to a G transformation; that is, relative to a trial in which AY
and AD are randomly assigned. The isolation conditions can thus be evaluated in G
transformation graphs, as opposed to extended causal DAGs. Note that in the case of
a treatment decomposition, the isolation conditions can be evaluated with respect to
either extended causal DAGs or their G transformations and the same conclusions will
be reached.
However, when treatments AY and AD are not components of A, we require additional
assumptions beyond (3) for the separable effects to explain the mechanism by which the
original treatment A exerts its effects on Yk+1 for k ∈ {0, . . . , K}. The following is an
alternative assumption to (2) that, when coupled with (3), is sufficient for the separable
effects to explain the total effect of the original treatment A on the event of interest
when AY and AD are not a decomposition of A. For variables, MY and MD, consider the
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following assumption:
AY and AD exert all their effects through MY and MD, respectively, and
MaY =a,aDY = M
a
Y for aD ∈ {0, 1}
MaY ,aD=aD = M
a
D for aY ∈ {0, 1},(25)
where the counterfactuals on the left and right hand side of the equality refer to assign-
ment to A = a and no level of AY and AD, and assignment to (AY = aY , AD = aD)
and no level of A, respectively. A transformed DAG that is consistent with (25) is shown
in Figure 10 where G′ refers to a six arm trial in which subjects are either randomly
assigned to A (and no level of AY and AD) or a combination of AY = aY and AD = aD
(and no level of A).
Note that assumptions (3) and (25) can, in principle, be falsified in a future randomized
experiment. For example, by randomly assigning individuals to A or a joint treatment
(AY , AD), we can assess whether E(W | AY = a,AD = a) 6= E(W | A = a), for any
W ∈ {Y1, . . . , YK+1, D1, . . . , Dk+1, Z1, . . . , Zk+1,MY ,MD}.
To fix ideas, consider a study of estrogen therapy versus placebo in men with prostate
cancer, which was the running example in Stensrud et al [6]. Estrogen therapy is thought
to reduce death due to prostate cancer, because it reduces testosterone levels and thus
prevents the cancer cells from growing. However, there is concern that estrogen therapy
may also increase mortality due to cardiovascular disease, e.g. through estrogen-induced
synthesis of coagulation factors [25]. Stensrud et al [6] used this example to motivate the
separable direct and indirect effects under full isolation, and suggested that alternative
treatments, such as castration and luteinizing hormone releasing hormone (LHRH) antag-
onists, can have the same effect as estrogen on testosterone reduction (MY ), but, unlike
estrogen, these treatments do not exert effects on the coagulation factors (MD). Whereas
Stensrud et al [6] did not formally define the variables MY and MD, providing the story
that includes these additional variables, satisfying (25), is essential to connect the effect
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A(G′)
AY (G
′)
AD(G
′)
MY (G
′)
MD(G
′)
Y1(G
′)
D1(G
′)
Y2(G
′)
D2(G
′)
L(G′)
Figure 10. Modified DAG including the additional variables MY and MD
and their relation to A, AY and AD.
of e.g. AY = 1 (here, assigning testosterone or LHRH antagonists) to the separable direct
and indirect effects of estrogen therapy (A) itself.
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Appendix B. Proof of identifiability
Before we provide a proof of identification formula (20), consider the following identi-
fiability conditions that generalize the conditions from Section 7 to allow for censoring.
1. Exchangeability:
Y¯ a,c¯=0K+1 , D¯
a,c¯=0
K+1 , L¯
a,c¯=0
K+1 ⊥ A | L0(26)
Y a,c¯=0k+1 , D
a,c¯=0
k+1 , L
a,c¯=0
k+1 ⊥ Ck+1 | Yk = Dk = C¯k = 0, L¯k, A(27)
Condition (26) holds when AY and AD are randomly assigned at baseline, possibly
conditional on L0. Condition (27) requires that losses to follow-up are independent
of future counterfactual events, given the measured past; this assumption does
not hold by design in a randomised trial, as losses to follow-up are not randomly
assigned in practice.
2. Positivity:
Pr(L0 = l0) > 0 =⇒
Pr(A = a | L0 = l0) > 0,(28)
fLk,Dk+1,Ck+1,Yk(lk, 0, 0, 0) > 0 =⇒
Pr(A = a|Dk+1 = Ck+1 = Yk = 0, Lk = lk) > 0(29)
Pr(A = a, Yk = 0, Dk = 0, C¯k = 0, L¯k = lk) > 0 =⇒
Pr(Ck+1 = 0 | Yk = 0, Dk = 0, C¯k = 0, L¯k = lk, A = a) > 0(30)
for a ∈ {0, 1}, k ∈ {0, . . . , K} and Lk ∈ L. Conditions (28) and (29) were de-
scribed in the main text. Condition (30) requires that for any possible history of
treatment assignment and covariates among those who are event-free and uncen-
sored at k, some subjects will remain uncensored at k + 1.
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3. Consistency:
if A = a and C¯k+1 = 0,
then Y¯k+1 = Y¯
a,c¯=0
k+1 , D¯k+1 = D¯
a,c¯=0
k+1 and L¯k+1 = L¯
a,c¯=0
k+1 .(31)
Consistency is satisfied if any individual who has data history consistent with the
intervention under a counterfactual scenario, would have an observed outcome
that is equal to the counterfactual outcome.
4. Dismissible component conditions:
Y c¯=0k+1 (G) ⊥ AD(G) | AY (G), Dc¯=0k+1(G) = Y c¯=0k (G) = 0, L¯c¯=0k (G),(32)
Dc¯=0k+1(G) ⊥ AY (G) | AD(G), Dc¯=0k (G) = Y c¯=0k (G) = 0, L¯c¯=0k (G),(33)
Lc¯=0AY ,k(G) ⊥ AD(G) | AY (G), Y c¯=0k (G) = Dc¯=0k (G) = 0, L¯c¯=0k−1(G), Lc¯=0AD,k(G),(34)
Lc¯=0AD,k(G) ⊥ AY (G) | AD(G), Dc¯=0k (G) = Y c¯=0k (G) = 0.L¯c¯=0k−1(G).(35)
The dismissible component conditions are identical to the conditions in Section
7, but the superscript c¯ = 0 is included to emphasize that we consider outcomes
in a setting in which loss to follow-up is eliminated even under G.
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Lemma 1. Under a FFRCISTG model, the dismissible component conditions (32)-(35)
imply the following equalities for aY , aD ∈ {0, 1}:
Pr(Y aY ,aD=0,c¯=0k+1 = 1 | Y aY ,aD=0,c¯=0k = 0, DaY ,aD=0,c¯=0k+1 = 0, L¯aY ,aD=0,c¯=0k = l¯k)
(36)
= Pr(Y aY ,aD=1,c¯=0k+1 = 1 | Y aY ,aD=1,c¯=0k = DaY ,aD=1,c¯=0k+1 = 0, L¯aY ,aD=1,c¯=0k = l¯k),
Pr(DaY =0,aD,c¯=0k+1 = 1 | Y aY =0,aD,c¯=0k = DaY =0,aD,c¯=0k = 0, L¯aY =0,aD,c¯=0k = l¯k)
(37)
= Pr(DaY =1,aD,c¯=0k+1 = 1 | Y aY =1,aD,c¯=0k = 0, DaY =1,aD,c¯=0k = 0, L¯aY =1,aD,c¯=0k = l¯k),
Pr(LaY ,aD=1,c¯=0AY ,k+1 = l
aY ,aD=1,c¯=0
AY ,k+1
| Y aY ,aD=1,c¯=0k+1 = DaY ,aD=1,c¯=0k+1 = 0,
(38)
L¯aY ,aD=1,c¯=0k = l¯k, L
aY ,aD=1,c¯=0
AD,k+1
= lAD,k+1)
= Pr(LaY ,aD=0,c¯=0AY ,k+1 = l
aY ,aD=0,c¯=0
AY ,k+1
| Y aY ,aD=0,c¯=0k+1 = DaY ,aD=0,c¯=0k+1 = 0,
L¯aY ,aD=0,c¯=0k = l¯k, L
aY ,aD=0,c¯=0
AD,k+1
= lAD,k+1),
Pr(LaY =0,aD,c¯=0AD,k+1 = l
aY =0,aD,c¯=0
AD,k+1
| Y aY =0,aD,c¯=0k+1 = DaY =0,aD,c¯=0k+1 = 0, L¯aY =0,aD,c¯=0k = l¯k)
(39)
= Pr(LaY =1,aD,c¯=0AD,k+1 = l
aY =1,aD,c¯=0
AD,k+1
| Y aY =1,aD,c¯=0k+1 = DaY =1,aD,c¯=0k+1 = 0, L¯aY =1,aD,c¯=0k = l¯k).
Proof.
Pr(Y aY ,aD=0,c¯=0k+1 = 1 | Y aY ,aD=0,c¯=0k = 0, DaY ,aD=0,c¯=0k+1 = 0, L¯aY ,aD=0,c¯=0k = l¯k)
= Pr(Y c¯=0k+1 (G) = 1 | Y c¯=0k (G) = 0, Dc¯=0k+1(G) = 0, L¯c¯=0k (G) = l¯k, AY (G) = aY , AD(G) = 0) by def. of G
= Pr(Y c¯=0k+1 (G) = 1 | Y c¯=0k (G) = 0, Dc¯=0k+1(G) = 0, L¯c¯=0k (G) = l¯k, AY (G) = aY , AD(G) = 1) due to (32)
= Pr(Y aY ,aD=1,c¯=0k+1 = 1 | Y aY ,aD=1,c¯=0k = 0, DaY ,aD=1,c¯=0k+1 = 0, L¯aY ,aD=1,c¯=0k = l¯k) by def. of G,
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which shows that equality (36) holds, and (37)-(39) can be shown from analogous ar-
guments, where we use conditions (33)-(35) in the second step, respectively, instead of
(32). 
Lemma 2. Suppose that conditions (26)-(31) hold. Then, for s = 0, . . . , K and aY , aD ∈
{0, 1},
Pr(Y aY =aD=a,c¯=0s+1 = 1 | DaY =aD=a,c¯=0s+1 = Y aY =aD=a,c¯=0s = 0, L¯aY =aD=a,c¯=0s = l¯s)(40)
= Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s = l¯s, A = a),
Pr(DaY =aD=a,c¯=0s+1 = 1 | DaY =aD=a,c¯=0s = Y aY =aD=a,c¯=0s = 0, L¯aY =aD=a,c¯=0s = l¯s)(41)
= Pr(Ds+1 = 1 | Cs+1 = Ds = Ys = 0, L¯s = l¯s, A = a),
Pr(LaY =aD=a,c¯=0AY ,s = lAY ,s | Y aY =aD=a,c¯=0s = DaY =aD=a,c¯=0s = 0, L¯aY =aD=a,c¯=0s = l¯s)(42)
= Pr(LAY ,s = l¯AY ,s | Cs = Ds = Ys = 0, L¯s−1 = l¯s−1, A = a),
Pr(LaY =aD=a,c¯=0AD,s = lAY ,s | Y aY =aD=a,c¯=0s = DaY =aD=a,c¯=0s = 0, L¯aY =aD=a,c¯=0s = l¯s)(43)
= Pr(LAY ,s = lAD,s | Cs = Ds = Ys = 0, L¯s−1 = l¯s−1, A = a).
Proof. Consider first (40),
Pr(Y aY =aD=a,c¯=0s+1 = 1 | DaY =aD=a,c¯=0s+1 = Y aY =aD=a,c¯=0s = 0, L¯aY =aD=a,c¯=0s = l¯s)
= Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s)
= Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = Y0 = D0 = C¯0 = 0, L0, L¯a,c¯=0s = l¯s)
=
Pr(Y a,c¯=0s+1 = 1, D¯
a,c¯=0
s+1 = Y¯
a,c¯=0
s = 0, L¯
a,c¯=0
s = l¯s | Y0 = D0 = C¯0 = 0, L0, A = a)
Pr(D¯a,c¯=0s+1 = Y¯
a,c¯=0
s = 0, L¯
a,c¯=0
s = l¯s | Y0 = D0 = C¯0 = 0, L0, A = a)
,
43
where we used the fact that all subjects are event-free and uncensored at t = 0, laws of
probability and (26). Using (27) and positivity,
Pr(Y a,c¯=0s+1 = 1, D¯
a,c¯=0
s+1 = Y¯
a,c¯=0
s = 0, L¯
a,c¯=0
s = l¯s | Y0 = D0 = C¯1 = 0, L0, A = a)
Pr(D¯a,c¯=0s+1 = Y¯
a,c¯=0
s = 0, L¯
a,c¯=0
s = l¯s | Y0 = D0 = C¯1 = 0, L0, A = a)
,
= Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y0 = D0 = C¯1 = 0, L0, A = a).
(44)
For s = 0, under consistency,
Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y0 = D0 = C¯1 = 0, L0, A = a)
= Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y0 = D1 = C¯1 = 0, L¯0, A = a)
= Pr(Y a,c¯=0s+1 = 1 | Y0 = D1 = C¯1 = 0, L¯0, A = a)
(45)
which proves the lemma for s = 0.
Further, for s > 1, using consistency,
Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y0 = D0 = C¯1 = 0, L0, A = a)
= Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y1 = D1 = C¯1 = 0, L¯1, A = a)
(46)
Apply (27) and positivity again,
Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y1 = D1 = C¯1 = 0, L¯1, A = a)
=
Pr(Y a,c¯=0s+1 = 1, D¯
a,c¯=0
s+1 = Y¯
a,c¯=0
s = 0, L¯
a,c¯=0
s = l¯s | Y1 = D1 = C¯2 = 0, L¯1, A = a)
Pr(D¯a,c¯=0s+1 = Y¯
a,c¯=0
s = 0, L¯
a,c¯=0
s = l¯s | Y1 = D1 = C¯2 = 0, L¯1, A = a)
,
= Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y ac¯=0s = 0, L¯a,c¯=0s = l¯s, Y1 = D1 = C¯2 = 0, L¯1, A = a).
(47)
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Using consistency,
Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y1 = D1 = C¯2 = 0, L¯1, A = a)
= Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s, Y2 = D2 = C¯2 = 0, L¯2, A = a)
(48)
Arguing iteratively, we find that
Pr(Y a,c¯=0s+1 = 1 | Da,c¯=0s+1 = Y a,c¯=0s = 0, L¯a,c¯=0s = l¯s)
= Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s = l¯s, A = a).(49)
Analogous arguments can be used to show (41)-(43). 
Theorem 1. Suppose conditions (26)-(35) hold. Then, for aY , aD ∈ {0, 1},
Pr(Y aY ,aD,c¯=0k+1 = 1)
=
∑
l¯K
[ K∑
s=0
Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s = l¯s, A = aY )
s∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aD)
× Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j−1 = l¯j−1, A = aY )
× Pr(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
× Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aD)
}]
.
Proof. If aY = aD ∈ {0, 1}, it is straightforward to use laws of probability to show that the
theorem holds. Consider now the case where aY 6= aD. In particular, let aY = 1 6= aD = 0.
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Using laws of probability and Lemma 1,
Pr(Y aY =1,aD=0,c¯=0K+1 = 1)
=
∑
l¯K
Pr(Y aY =1,aD=0,c¯=0K+1 = 1 | L¯aY =1,aD=0,c¯=0K ) Pr(L¯aY =1,aD=0,c¯=0K = L¯aY =1,aD=0,c¯=0K = l¯K)
=
∑
l¯K
[ K∑
s=0
Pr(Y aY =1,aD=0,c¯=0s+1 = 1 | DaY =1,aD=0,c¯=0s+1 = Y aY =1,aD=0,c¯=0s = 0, L¯aY =1,aD=0,c¯=0s = l¯s)
s∏
j=0
{
Pr(DaY =1,aD=0,c¯=0j+1 = 0 | DaY =1,aD=0,c¯=0j = Y aY =1,aD=0,c¯=0j = 0, L¯aY =1,aD=0,c¯=0j = l¯j)
× Pr(Y aY =1,aD=0,c¯=0j = 0 | DaY =1,aD=0,c¯=0j = Y aY =1,aD=0,c¯=0j−1 = 0, L¯aY =1,aD=0,c¯=0j = l¯j)
× Pr(LaY =1,aD=0,c¯=0AY ,j = lAY ,j | Y aY =1,aD=0,c¯=0j = DaY =1,aD=0,c¯=0j = 0, L¯aY =1,aD=0,c¯=0j−1 = l¯j−1,
LaY =1,aD=0,c¯=0AD,j = lAD,j)
× Pr(LaY =1,aD=0,c¯=0AD,j = lAD,j | Y aY =1,aD=0,c¯=0j = DaY =1,aD=0,c¯=0j = 0, L¯aY =1,aD=0,c¯=0j−1 = l¯j−1)
}]
=
∑
l¯K
[ K∑
s=0
Pr(Y a=1,c¯=0s+1 = 1 | Da=1,c¯=0s+1 = Y a=1,c¯=0s = 0, L¯AY =AD=a1,c¯=0s )
s∏
j=0
{
Pr(Da=0,c¯=0j+1 = 0 | Da=0,c¯=0j = Y a=0,c¯=0j = 0, L¯a=0,c¯=0j = l¯j)
× Pr(Y a=1,c¯=0j = 0 | Da=1,c¯=0j = Y a=1,c¯=0j−1 = 0, L¯a=1,c¯=0j = l¯j)
× Pr(La=1,c¯=0AY ,j = lAY ,j | Y a=1,c¯=0j = Da=1,c¯=0j = 0, L¯a=1,c¯=0j−1 = l¯j−1, La=1,c¯=0AD,j = lAD,j)
× Pr(La=0,c¯=0AD,j = lAD,j | Y a=0,c¯=0j = Da=0,c¯=0j = 0, L¯a=0,c¯=0j−1 = l¯j−1)
}]
,
(50)
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where Y aY ,aD,c¯=0−1 , and L
aY ,aD,c¯=0
−1 are empty sets. Using Lemma 2, we can substitute the
terms in the last equality in (50),
=
∑
l¯K
[ K∑
s=0
Pr(Y a=1,c¯=0s+1 = 1 | Da=1,c¯=0s+1 = Y a=1,c¯=0s = 0, L¯AY =AD=aY ,c¯=0s )
s∏
j=0
{
Pr(Da=0,c¯=0j+1 = 0 | Da=0,c¯=0j = Y a=0,c¯=0j = 0, L¯a=0,c¯=0j = l¯j)
× Pr(Y a=1,c¯=0j = 0 | Da=1,c¯=0j = Y a=1,c¯=0j−1 = 0, L¯a=1,c¯=0j = l¯j)
× Pr(La=1,c¯=0AY ,j = lAY ,j | Y a=1,c¯=0j = Da=1,c¯=0j = 0, L¯a=1,c¯=0j−1 = l¯j−1, La=1,c¯=0AD,j = lAD,j)
× Pr(La=0,c¯=0AD,j = lAD,j | Y a=0,c¯=0j = Da=0,c¯=0j = 0, L¯a=0,c¯=0j−1 = l¯j−1)
}]
=
∑
l¯K
[ K∑
s=0
Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s = l¯s, A = aY )
s∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aD)
× Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j−1 = l¯j−1, A = aY )
× Pr(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
× Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aD)
}]
.

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Appendix C. Zk partition and the dismissible component conditions
Lemma 3. Zk partition fails if and only if any of the following statements are true for
some k ∈ {1, . . . , K}: (i) there is a direct arrow from AY into Dk+1, (ii) there is a direct
arrow from AD into Yk+1, or (iii) there exists a node W ∈ Z¯k such that there are direct
arrows from both AY and AD into W .
Proof. First we directly show that if (i), (ii) or (iii) holds then Zk partition fails. If (i)
holds then (8) is violated by the presence of a causal path Ay → Dk+1 and therefore Zk
partition is violated. If (ii) holds then (9) is violated by the presence of a causal path
AD → Yk+1 and therefore Zk partition is violated. Now suppose (iii) is true and define
a partition of Zk such that W ∈ Z¯AD,k. Then a causal path AY → W will exist and (8),
and therefore Zk partition, is violated. Alternatively suppose (iii) is true and define a
partition of Zk such that, instead, W ∈ Z¯AY ,k Then a causal path AD → W will exist
and (9), and therefore Zk partition, is violated.
Next we show by contradiction that if Zk partition fails then (i), (ii) or (iii) must hold.
Suppose Zk partition holds and (i), (ii) or (iii) also holds. If (i), (ii) or (iii) holds then
one of the following causal paths must be present: AY → Dk+1, for some k ∈ {1, . . . , K};
AD → Yk+1, for some k ∈ {1, . . . , K}; AY → W for some W ∈ Z¯AD,K ; or AD → W for
some W ∈ Z¯AY ,K . The presence of any of these paths violates either (8) or (9) such that
Zk partition fails. Thus, we have a contradiction and we are done.

Lemma 4. If Zk partition fails, then at least one of the dismissible component conditions
fail.
Proof. Suppose Zk partition fails. Then, by lemma 3, (i), (ii) or (iii) must hold such
that at least one of the following paths must be present for W ∈ Z¯j, j ≤ k, a cause
of Yk+1 and/or Dk+1, for some k ∈ {1, . . . , K}: AY → Dk+1; AD → Yk+1; AY →
W → . . . → Dk+1 and AD → W → . . . → Dk+1; or AD → W → . . . → Yk+1 and
AY → W → . . .→ Yk+1.
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If the path AY → Dk+1 is present then the dismissible component condition(16) fails
for any choice of Lk. If the path AD → Yk+1 is present then the dismissible component
condition (15) fails for any choice of Lk.
Suppose W /∈ L¯K , (W is unmeasured). If the path AY → W → . . .→ Dk+1 is present
then the dismissible component condition (16) fails for any choice of Lk. If the path
AD → W → Yk+1 is present then the dismissible component condition (15) fails for any
choice of Lk.
Suppose W ∈ L¯j+1 for some j ∈ {0, . . . , K} (W is measured). If the paths AY →
W → . . . → Dk+1 and AD → W → . . . → Dk+1 are present then, no matter our choice
of Lj, if we choose W ∈ L¯AY ,j+1 the dismissible component condition (17) fails and if
we choose W ∈ L¯AD,j+1 the dismissible component condition (18) fails. Similarly, if the
paths AD → W → . . . → Yk+1 and AY → W → . . . → Yk+1 are present then, no matter
our choice of Lj, if we choose W ∈ L¯AY ,j+1 the dismissible component condition (17) fails
and if we choose W ∈ L¯AD,j+1 the dismissible component condition (18) fails.

Lemma 5. If the dismissible component conditions hold when we define LAY ,K = ∅, then
AY partial isolation holds.
Proof. We give a proof by contradiction. Suppose the dismissible component conditions
hold under LAY ,k = ∅, but AY partial isolation does not hold. Then, if there is a direct
arrow AY → Dk+1 for any k ∈ {0, . . . , K}, this arrow would violate (16), which is a
contradiction. Alternatively, AY partial isolation can only be violated if there exists
a W such that AY → W → ... → Dk+1 for any k ∈ {0, . . . , K}. However, if W is
measured then W ∈ LAD,k (because LAY ,k = ∅), and then (18) is violated, which is a
contradiction. If W is unmeasured, then either (16) is violated or (18) is violated, which
is a contradiction. 
Lemma 6. If the dismissible component conditions hold when we define LAD,k = ∅, then
AD partial isolation holds.
Proof. The proof is analogous to the proof of lemma 5. 
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Lemma 7. If the dismissible component conditions hold for both the partition LAD,k =
∅, LAY ,k = Lk and the partition LAY ,k = Lk, LAD,k = ∅, then full isolation holds.
Proof. It follows immediately from Lemma 5 and Lemma 6, because full isolation holds
by definition if both AY partial isolation and AD partial isolation holds. 
Lemma 8. If the dismissible component conditions hold for both the partition LAD,k =
∅, LAY ,k = Lk and the partition LAY ,k = Lk, LAD,k = ∅, then
Lk+1 ⊥ A | Dk+1 = Yk+1 = 0, L¯k.
Proof. We give a proof by contradiction. Suppose that the dismissible component con-
ditions hold for both the partition LAD,k = ∅, LAY ,k = Lk and the partition LAY ,k =
Lk, LAD,k = ∅, and there is a conditional dependence such that
Lk 6⊥⊥ A | Dk = Yk = 0, L¯k−1,
for at least one k = 0, . . . , K. Using the rules of d-separation [5], we will consider the 4
possible ways in which A and Lk can be d-connected, conditional on Dk = Yk = 0, L¯k−1.
Suppose that the conditional dependence is due to a direct arrow from A into Lk.
Then, under the generalized decomposition assumption, either there is a direct arrow
from AD into Lk or a direct arrow from AY into Lk, and these arrows would, repsectively,
violate (17) under the partition LAY ,k = Lk, LAD,k = ∅ and (18) under the partition
LAD,k = Lk, LAY ,k = ∅, which is a contradiction.
Suppose that the conditional dependence is due the unmeasured common cause W
of of A and Lk. Then, under the generalized decomposition assumption, either (i) W
is a common cause of either AY and Lk or (ii) W is a common cause of AD and Lk.
However, (i) or (ii) would violate dismissible component condition (17) or (18), which is
a contradiction.
Suppose that the conditional dependence is due to an unblocked path due to condition-
ing on Dk = 0, Yk = 0 and L¯k−1, that is, by conditioning on a collider or a descendant of
a collider. Then, under the generalized decomposition assumption, this path would lead
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to a conditional dependence between either Lk and AY or Lk and AD. Any such path
would violate (17) or (18), which is a contradiction of the result in Lemma 7.
Finally, suppose that the conditional dependence is due to a direct arrow from Lk
where k = 1, . . . , K into A. This would violate our assumption of a temporal order, that
is, it would imply that A occurs after Lk, which is a contradiction. 
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Appendix D. Proof of weighted representation of (20)
First, using laws of probability we can re-formulate the weights WLAY ,k and WLAD ,k,
WLAD ,k(aY , aD) =
∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, LAD,j, L¯j−1 = l¯j−1)∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, LAD,j, L¯j−1 = l¯j−1)
×
∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1)∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1)
=
∏k
j=0
Pr(A=aD|Cj=Yj=Dj=0,LAD,j ,L¯j−1=l¯j−1) Pr(Cj=Yj=Dj=0,LAD,j ,L¯j−1=l¯j−1)
Pr(Cj=Yj=Dj=0,L¯j−1=l¯j−1,A=aD)∏k
j=0
Pr(A=aY |Cj=Yj=Dj=0,LAD,j ,L¯j−1=l¯j−1)f(Cj=Yj=Dj=0,LAD,j ,L¯j−1=l¯j−1)
Pr(Cj=Yj=Dj=0,L¯j−1=l¯j−1,A=aY )
=
∏k
j=0 Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aD)∏k
j=0 Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aY )
,
and
WLAY ,k(aY , aD) =
∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, L¯j = l¯j)∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, L¯j = l¯j)
×
∏k
j=0 Pr(A = aD | Cj = Yj = Dj = 0, LAD,j, L¯j−1 = l¯j−1)∏k
j=0 Pr(A = aY | Cj = Yj = Dj = 0, LAD,j, L¯j−1 = l¯j−1)
=
∏k
j=0
Pr(A=aY |Cj=Yj=Dj=0,L¯j=l¯j) Pr(Cj=Yj=Dj=0,L¯j=l¯j)
f(Cj=Yj=Dj=0,LAD,j ,L¯j−1=l¯j−1,A=aY )∏k
j=0
Pr(A=aD|Cj=Yj=Dj=0,L¯j=l¯j)f(Cj=Yj=Dj=0,L¯j=l¯j)
f(Cj=Yj=Dj=0,LAD,j ,L¯j−1=l¯j−1,A=aD)
=
∏k
j=0 f(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, LAD,j, L¯j−1 = l¯j−1, A = aY )∏k
j=0 f(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, LAD,j, L¯j−1 = l¯j−1, A = aD)
.
Define
W ′C,k(aY ) =
1∏k
j=0 Pr(Cj+1 = 0 | Cj = Dj = Yj = 0, L¯j = l¯j, A = aD)
.
52
Consider the expression
E[WC,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)Yk+1(1− Yk)(1−Dk+1) | A = aY ]
=E[W ′C,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)Yk+1(1− Yk)(1−Dk+1)(1− Ck+1) | A = aY ]
=
∑
l¯k
∑
y¯k+1
∑
d¯k+1
[f(y¯k+1, dk+1, ck+1, l¯k | A = aY )W ′C,k(a)WD,k(aY , aD)WLAD ,k(aY , aD)
× yk+1(1− yk)(1− dk+1)(1− ck+1)]
=
∑
l¯k
[Pr(Yk+1 = 1, Yk = Dk+1 = Ck+1 = 0, l¯k | A = aY )W ′C,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)]
=
∑
l¯k
[Pr(Yk+1 = 1 | Yk = Dk+1 = Ck+1 = 0, l¯k, A = aY ) Pr(Dk+1 = 0 | C¯k+1 = D¯k = Y¯k = 0, l¯k, A = aY )
× Pr(Ck+1 = 0 | D¯k = Y¯k = C¯k = 0, l¯k, A = aY )f(l¯k | C¯k = D¯k = Y¯k = 0, A = aY )
× Pr(Y¯k = D¯k = C¯k = 0 | A = aY )
×W ′C,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)]
=
∑
l¯k
[Pr(Yk+1 = 1 | Yk = Dk+1 = Ck+1 = 0, l¯k, A = aY ) Pr(Dk+1 = 0 | C¯k+1 = D¯k = Y¯k = 0, l¯k, A = aY )
× Pr(Ck+1 = 0 | D¯k = Y¯k = C¯k = 0, l¯k, A = aY )f(lk | Y¯k = D¯k = C¯k = 0, l¯k−1, A = aY )
× Pr(Y¯k = D¯k = C¯k = 0, L¯k−1 = lk−1 | A = aY )
×W ′C,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)],
where we use the definition of expected value in the second equation, the fact that Yk and
Dk are binary in the third equation, laws of probability in the fourth and fifth equation.
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We use laws of probability to express f(Y¯k = D¯k = C¯k = 0, l¯k−1 | A = aY ) as
Pr(Yk = 0 | Ck = Dk = Yk−1 = 0, l¯k−1, A = aY )
× Pr(Dk = 0 | Ck = Dk−1 = Yk−1 = 0, l¯k−1, A = aY )
× Pr(Ck = 0 | Dk−1 = Yk−1 = Ck−1 = 0, l¯k−1, A = aY )
× f(lk−1 | Ck−1 = Dk−1 = Yk−1 = 0, l¯k−2, A = aY )
× f(Y¯k−1 = D¯k−1 = 0, l¯k−2, C¯k−1 = 0 | A = aY ),
where any variable indexed with a number m < 0 is defined to be the empty set.
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Arguing iteratively for k − 1, k − 2, ..., 0 we find that
E[W ′C,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)Yk+1(1− Yk)(1−Dk+1)(1− Ck+1) | A = aY ]
=
∑
l¯k
[
Pr(Yk+1 = 1 | Yk = Dk+1 = Ck+1 = 0, l¯k, A = aY )
k∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aY )
× Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j−1 = l¯j−1, A = aY )
× Pr(Cj+1 = 0 | D¯j = Y¯j = C¯j = 0, L¯j = l¯j, aY )
× Pr(Lj = lj | Cj = Dj = Yj = 0, L¯j−1 = l¯j−1, A = aY )
}
×W ′C,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)
]
=
∑
l¯k
[
Pr(Yk+1 = 1 | Yk = Dk+1 = Ck+1 = 0, l¯k, A = aY )
k∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aY )
× Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j−1 = l¯j−1, A = aY )
× Pr(Cj+1 = 0 | D¯j = Y¯j = C¯j = 0, L¯j = l¯j, A = aY )
× Pr(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aY )
}
×W ′C,k(aY )WD,k(aY , aD)WLAD ,k(aY , aD)
]
,
where we use that Lk = (LAY ,k, LAD,k) in the second equality.
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By plugging in the expression for W ′C,k(aY ), we get
=
∑
l¯k
[Pr(Yk+1 = 1 | Yk = Dk+1 = Ck+1 = 0, L¯k = l¯k, A = aY )
×
k∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aY )
× Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j = l¯j, A = aY )
× Pr(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
× Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aY )
}
×WD,k(aY , aD)WLAD ,k(aY , aD)],
By plugging in the expression for the weights WLAD ,k(aY , aD) and WD,k(aY , aD) we obtain
=
∑
l¯k
[Pr(Yk+1 = 1 | Yk = Dk+1 = Ck+1 = 0, L¯k = l¯k, A = aY )
×
k∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aD)
× Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j = l¯j, A = aY )
× Pr(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
× Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aD)
}
,
and the final expression is equal to (20).
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Appendix E. Treatment decomposition of A into AY , AD and AZ
Hitherto we have described settings in which the treatment is decomposed into 2 com-
ponents, AD and AY . Consider now a hypothetical treatment decomposition into 3
components AD, AY and AZ , as illustrated in Figure 11, which is similar to Robins and
Richardson’s decomposition in a mediation setting [7, Figure 6(d)]. Analogous to the 2
way decomposition, we define a generalized decomposition assumption:
3 way generalized decomposition assumption: The treatment A can be decom-
posed into three binary components AY ∈ {0, 1}, AD ∈ {0, 1} and AZ ∈ {0, 1}
such that, in the observed data, the following determinism holds
A ≡ AD ≡ AY ≡ AZ ,(51)
but, in a future study, AY ,AD and AZ could be assigned different values under
a hypothetical intervention. For any individual in the study population and for
k ∈ {0, . . . , K}, let Y aY ,aD,aZk+1 be the indicator of the event of interest by interval
k + 1 had, possibly contrary to fact, he/she been assigned to AY = aY , AD = aD
and AZ = aZ , where aY , aD, aZ ∈ {0, 1}. We assume that an intervention that
assigns A = a results in the same outcome as an intervention that assigns AY =
AD = AZ = a, that is,
QaY =aD=aZ=ak+1 = Q
a
k+1,(52)
for Qk+1 ∈ {Yk+1, Dk+1, Zk+1}. Analogous to the 2 way decomposition, the 3 way decom-
position may be practically interesting in settings where we can conceive interventions on
all 3 components of A. Furthermore, in settings where Zk partition fails, it may be pos-
sible to define a 3 way decomposition that allows identifiability of separable effects. For
example, Figure 11 can represent an alternative decomposition of the setting described
in Figure 5a, where Zk partition fails.
To define identifiability conditions that apply to settings with 3 way decompositions,
we continue to use superscripts to denote counterfactuals and for notational simplicity we
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consider settings without censoring, such that e.g. Y aY ,aD,aZk+1 is the counterfactual value
of Yk+1 if, possibly contrary to fact, AY = aY , AD = aD, AZ = aZ ∈ {0, 1}.
Here we will only consider settings that satisfy the following assumptions:
the only causal paths from AY to Dk+1 and Zk+1, k ∈ {0, . . . , K} are through Yj,
j = 0, ..., k,(53)
the only causal paths from AD to Yk+1 and Zk+1, k = 0, . . . , K are through Dj+1,
j = 0, . . . , k.(54)
the only causal paths from AZ to Yk+1 and Dk+1, k = 0, . . . , K are through Zj+1,
j = 0, . . . , k.(55)
For k = 0, . . . , K, consider the separable effects
(56) Pr(Y aY =1,aD,aZk+1 = 1) vs. Pr(Y
aY =0,aD,aZ
k+1 = 1),
for aD, aZ ∈ {0, 1},
(57) Pr(Y aY ,aD=1,aZk+1 = 1) vs. Pr(Y
aY ,aD=0,aZ
k+1 = 1),
for aY , aZ ∈ {0, 1}, and
(58) Pr(Y aY ,aD,aZ=1k+1 = 1) vs. Pr(Y
aY ,aD,aZ=0
k+1 = 1),
for aY , aD ∈ {0, 1}.
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Similar to the two component decomposition, the total effect can be expressed as a
sum of the separable direct and indirect effects, in particular,
Pr(Y aY =1,aD=1,aZ=1k+1 = 1)− Pr(Y aY =0,aD=1,aZ=1k+1 = 1)
+ Pr(Y aY =0,aD=1,aZ=1k+1 = 1)− Pr(Y aY =1,aD=0,aZ=1k+1 = 1)
+ Pr(Y aY =0,aD=0,aZ=1k+1 = 1)− Pr(Y aY =0,aD=0,aZ=0k+1 = 1)
= Pr(Y a=1k+1 = 1)− Pr(Y a=0k+1 = 1).
E.1. Interpretation of the 3 component decomposition. Under (53)-(55), the 3
way decomposition of A into AD, AY and AZ allows us to interpret the separable effects
as direct and indirect effects; (56) is the effect not emanating from AD or AZ , i.e. a
separable direct effect, (57) is the separable indirect effect on the event of interest only
emanating from AD, and (58) is the separable indirect effect on the event of interest only
emanating from AZ .
In our running example, where Zk = Lk encodes the (systolic and diastolic) blood
pressure, it is not obvious that the 3 part decomposition is of interest; to interpret
effects defined by the 3 part decomposition, we would need to conceptualize a treatment
decomposition of blood pressure therapy into 3 components: theAD component could now
be defined as the component that exerts effects on mortality not through blood pressure
reduction or kidney injury; that is, the substantive meaning of an intervention on AD
fundamentally changes. The AZ component would affect the outcome of interest only
through blood pressure reduction; the effect exerted by AZ is analogous to an indirect
mediation effect described by Didelez [8] under an agnostic causal model, but in our
setting we also allow for competing risks. We note that under this 3 way decomposition,
the AY component is identical to the AY component in the 2 way decomposition, that
is, the component of blood pressure therapy only exerting direct effects on kidney injury
not through blood pressure reduction.
In other settings, however, the 3 part decomposition may be feasible. For example,
Robins and Richardson [7, Figure 6(d)] consider a similar decomposition in a conceptual
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example on the effect of cigarettes on lung cancer; they consider the effect of cigarettes
smoking through nicotine, tar and other pathways.
E.2. Identification of the 3 component decomposition. The identifiability condi-
tions are straightforward extensions of the conditions in Section 7. Now we must identify
Pr(Y aY ,aD,aZk+1 = 1) for aY , aD, aZ ∈ {0, 1}.
First the exchangeability, consistency and positivity conditions are identical to the
condition in Section 7. The dismissible component conditions read
Yk+1(G) ⊥ (AD(G), AZ(G)) | AY (G), Yk(G) = Dk+1(G) = 0, L¯k(G),
Dk+1(G) ⊥ (AY (G), AZ(G)) | AD(G), Dk(G) = Yk(G) = 0, L¯k(G),
Lk+1(G) ⊥ (AY (G), AD(G)) | AZ(G), Dk+1(G) = Yk+1(G) = 0, L¯k(G).
Under these assumptions we can identify Pr(Y aY ,aD,aZk+1 = 1) for k = 0, . . . , K from
∑
l¯k
[ k∑
s=0
Pr(Ys+1 = 1 | Ds+1 = Ys = 0, L¯s = l¯s, A = aY )
s∏
j=0
{
Pr(Dj+1 = 0 | Dj = Yj = 0, L¯j = l¯j, A = aD)
× Pr(Yj = 0 | Dj = Yj−1 = 0, L¯j−1 = l¯j−1, A = aY )
× Pr(Lj = lAY ,j | Yj = Dj = 0, L¯j−1 = l¯j−1, A = aZ)
}]
,(59)
which follows from a similar derivation from that in Appendix B. The identifiability
conditions under the 3 component decomposition require stronger restrictions on the un-
measured variables, compared to the settings in Section 7; unmeasured common causes
of any pair in (Yk+1, Dj+1, Lm+1), k, j,m ∈ {0, . . . , K} can violate the dismissible com-
ponent conditions. In particular, an unmeasured common cause UL,Y of Lk and Yk will
violate the dismissible component condition, as shown in grey in Figure 12.
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A AY
AD
AZ
Y1
D1
Y2
D2
Z1
Figure 11. Treatment A is decomposed into 3 components.
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A AY
AD
AZ
Y1
D1
Y2
D2
L1 UL,Y
Figure 12. Treatment is decomposed into 3 components, such that L1 =
Z1. The variable UL,Y would violate the dismissible component conditions
here.
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Appendix F. Estimation algorithms
Here we describe an algorithm to estimate the separable effects using estimators based
on (21); i.e. the estimator νˆ1,aY ,aD,k described in Section 9. We initially construct our
input data set such that each subject has K∗ + 1 lines, indexed by k = 0, . . . , K∗, and
there are measurements of (A,Ck+1, Dk+1, Yk+1, L¯k+1) on each line k. For each subject,
K∗ = K if CK+1 = DK+1 = YK+1 = 0, otherwise K∗ = m, where Cm = Dm = Ym = 0
and either Cm+1 = 1, Dm+1 = 1 or Ym+1 = 1. Due to the temporal ordering, we do the
following: if Ck+1 = 1, then Dk+1 and Yk+1 are set missing. Similarly, if Ck+1 = 0 and
Dk+1 = 1, then Yk+1 = 1 is set missing. Then we do the following to estimate (21) at K:
(1) Using all subject-intervals records, i.e. all lines in the data set, obtain αˆD by
fitting a parametric model (e.g. pooled logistic regression model) with dependent
variable Dk+1 and independent variables a specified function of k = 0, . . . K, L¯k
and A.
(2) Using all subject-intervals records, obtain αˆC by fitting a parametric model (e.g.
pooled logistic regression model) with dependent variable Ck+1 and independent
variables a specified function of k = 0, . . . K, L¯k and A.
(3) Using all subject-intervals records, estimate αˆLD,1 by fitting a parametric model
with dependent variable A and independent variables a specified function of k =
0, . . . K, L¯k and A.
(4) Using all subject-intervals records, estimate αˆLD,2 by fitting a parametric model
with dependent variable A and independent variables a specified function of k =
0, . . . K, L¯k−1,LAD,k and A, ensuring that the models used to fit αˆLD,1 and αˆLD,2
are compatible. Notice that this step is redundant if we can define a Lk partition
such that LAD,k = ∅, k = 0, . . . K, which implies that AD partial isolation holds.
(5) For subject i, attach a weight to line k with predicted outcome probabilities de-
rived from the parametric models indexed by parameters αˆD, αˆLD1, αˆLD2 and αˆC to
estimate Wˆ1,i,k(aY , aD; αˆ1) = Wˆi,D,k(aY , aD; αˆD)Wˆi,LAD ,k(aY , aD; αˆLD1, αˆLD2)Wˆi,C,k(aY ; αˆC).
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(6) Compute an estimate of Pr(Y aY ,aD,c¯=0K+1 ) from
1∑n
j=1 I(Aj = aY )
n∑
i=1
K∑
k=0
Wˆ1,i,k(aY , aD; αˆ1)Yi,k+1(1− Yi,k)(1−Di,k+1)I(Ai = aY ).
An estimator based on (22) could be derived analogously, where step (1) we would fit a
model with Yk+1 as dependent variable, in step (4) we would fit a model where we replace
LAD,k with LAY ,k, and we finally compute an estimate of Pr(Y
aY ,aD,c¯=0
K+1 ) from
1∑n
j=1 I(Aj = aD)
n∑
i=1
K∑
k=0
Wˆ2,i,k(aY , aD; αˆ1)Yi,k+1(1− Yi,k)(1−Di,k+1)I(Ai = aD).
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Appendix G. Sensitivity analysis
To illustrate a sensitivity analysis technique for violations of the dismissible component
conditions, consider a selection bias function for dismissible component condition (15),
tk(l¯k, aY ) = Pr(Y
aY ,aD=0,c¯=0
k+1 = 1 | DaY ,aD=0,c¯=0k+1 = Y aY ,aD=0,c¯=0k = 0, L¯aY ,aD=0,c¯=0k = l¯k)
− Pr(Y aY ,aD=1,c¯=0k+1 = 1 | DaY ,aD=1,c¯=0k+1 = Y aY ,aD=1,c¯=0k = 0, L¯aY ,aD=1,c¯=0k = l¯k),
which is identified in a setting in which AY and AD are randomly assigned. Analogous
sensitivity functions could be defined for dismissible component conditions (16)-(18). If
dismissible component condition (15) holds for L¯k, we know that t(L¯k, aY ) = 0. However,
if (15) was violated, we would expect that tk(l¯k, aY ) 6= 0 for some values of l¯k and aY . In
particular, we would expect (15) to be violated in the presence of any unmeasured cause
of Yk and Dj, where 0 < j ≤ k.
While the following strategy for sensitivity analysis is applicable to any setting in which
Zk partition holds, we consider a simpler setting in which (i) AY partial isolation holds,
(ii) dismissible component condition (15) is satisfied for some L′ ≡ L′D which contains
the measured variable L as a subset, L ⊂ L′, and (iii) dismissible component condition
(16)-(18) are satisfied. This is coherent with our blood pressure example in Section 10,
and one such setting is described in Figure 7f where (15) is violated due to failure of
measuring UL,Y . Now, suppose that tk(l¯k, aY ) is known. Then the separable effects can
be identified through the modified version of identification formula (22),
k∑
s=0
E{WC,s(aD)W †Y,s(aD, aY )(1− Ys)(1−Ds+1)Ys+1 | A = aD},(60)
where
W †Y,s(aD, aY ) =
(−1)aY ts+1(l¯s+1, aY ) + Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s, A = aY )
Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s, A = aD)
×
∏s−1
j=0(−1)aY tj(l¯j, aY ) + Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j, A = aY )∏s−1
j=0 Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j, A = aD)
,
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which is equal to (22) under AY partial isolation when tk(l¯k, aY ) = 0 for all k, l¯k and aY .
Formula (60) motivates the estimator νˆ†2,aY ,aD,k, a modified version of νˆ2,aY ,aD,k from Sec-
tion 9, such that νˆ†2,aY ,aD,k is the solution to the estimating equation
∑n
i=1 U
†
2,k,i(νaY ,aD,k, αˆ2) =
0 with respect to νaY ,aD,k, where
U †2,k,i(νaY ,aD,k, αˆ2)
=I(Ai = aD)
[ k∑
s=0
{WˆC,s,i(aD; αˆC)Wˆ †2,s,i(aY , aD; αˆ2)Ys+1,i(1− Ys,i)(1−Ds+1,i)} − νaY ,aD,k
]
,
and Wˆ †2,s,i(aY , aD; αˆ2) = WˆC,s,i(aD; αˆC)Wˆ
†
Y,s,i(aD, aY ; αˆY ), where
Wˆ †Y,k,i(aD, aY ; αˆY )
=
(−1)aY tk+1(l¯k+1, aY ) + Pr(Yk+1 = 1 | Ck+1 = Dk+1 = Yk = 0, L¯k,i, A = aY ; αˆY )
Pr(Yk+1 = 1 | Cj+1 = Dk+1 = Yk = 0, L¯k,i, A = aD; αˆY )
×
∏k−1
j=0(−1)aDtj+1(l¯j+1, aY ) + Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j,i, A = aY ; αˆLY 1)∏k−1
j=0 Pr(Yj+1 = 0 | Cj+1 = Dj+1 = Yj = 0, L¯j,i, A = aD; αˆLY 1)
.
Proof. The following equality holds by definition of tk(l¯k, aY ),
Pr(Y aY ,aD=0,c¯=0k+1 = 1 | Y aY ,aD=0,c¯=0k = DaY ,aD=0,c¯=0k+1 = 0, L¯aY ,aD=0,c¯=0k = l¯k)
=tk(l¯k, aY ) + Pr(Y
aY ,aD=1,c¯=0
k+1 = 1 | Y aY ,aD=1,c¯=0k = DaY ,aD=1,c¯=0k+1 = 0, L¯aY ,aD=1,c¯=0k = l¯k).
(61)
While (36) of Lemma 1 is violated in our setting where dismissible component condition
(15) is violated, note that (37)-(39) of Lemma 1 holds and that Lemma 2 holds regardless
of violations of the dismissible component conditions. Thus, following analogous steps as
in the proof of Theorem 1, we use (26)-(31), (33)-(35), as well as (61) instead of (32), to
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obtain the following identification formula for settings where aY 6= aD,
Pr(Y aY ,aD,c¯=0k+1 = 1)
=
∑
l¯K
[ K∑
s=0
(−1)aY tk(l¯k, aY ) + Pr(Ys+1 = 1 | Cs+1 = Ds+1 = Ys = 0, L¯s = l¯s, A = aY )
s∏
j=0
{
Pr(Dj+1 = 0 | Cj+1 = Dj = Yj = 0, L¯j = l¯j, A = aD)
× [(−1)aDtk(l¯k, aY ) + Pr(Yj = 0 | Cj = Dj = Yj−1 = 0, L¯j−1 = l¯j−1, A = aY )]
× Pr(LAY ,j = lAY ,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, LAD,j = lAD,j, A = aY )
× Pr(LAD,j = lAD,j | Cj = Yj = Dj = 0, L¯j−1 = l¯j−1, A = aD)
}]
,
and a weighted representation of this identification formula is analogous to identification
formula (22), where Wˆ2,s(aY , aD) is replaced by W
†
Y,s(aD, aY ), which can be shown by an
argument that is analogous to the proof in Appendix D.

Now a formal sensitivity analysis can be conducted by repeatedly estimating νˆ†2,aY ,aD,k
for each choice of tk(l¯k, aY ) for a set of functions T = {tk,λ(l¯k, aY ) : λ}, where λ is a
finite dimensional parameter and tk,0(l¯k, aY ) ≡ 0 describes the setting with no bias, that
is, no unmeasured common causes of Yk and Dj or of Yk and Lj, for any j, k such that
0 < j ≤ k.
Subject matter knowledge may help us to reason about the sensitivity function tk(l¯k, aY ).
To fix ideas, suppose that the graph in Figure 7f represents the blood pressure example,
where UL,Y is an unmeasured common cause that increases the blood pressure (Lk) and
the risk of kidney failure (Yk). Then we would expect tk(l¯k, aY ) to be negative due to se-
lection over time: subjects who do not receive the treatment component that intensively
reduces blood pressure (aD = 0) are less likely to be alive with larger values of UL,Y
compared to those who received the component that intensively reduces blood pressure
(aD = 1).
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Our sensitivity analysis technique is inspired by Tchetgen Tchetgen [26]. However,
unlike Tchetgen Tchetgen [26], the terms in our sensitivity function are not cross-world
quantities that are unobservable in principle, but conditional expectations that can be
identified in an experiment in which AY and AD are randomly assigned.
Furthermore, note that our identification results from Section 7 also motivate sensitivity
analyses of violations of the isolation conditions from Section 6. In particular, suppose
that an investigator assumed that full isolation was satisfied and, thus, used the simplified
identification formula that was introduced in Stensrud et al [6]. Then, the assumption
of full isolation could be falsified by comparing these estimates to estimates derived from
the estimators in Section 9, only assuming Zk partition. To do this sensitivity analysis,
the investigator need to measure a set of time-varying covariates Lk, k ∈ {0, . . . , K}.
